Yes, this is what I've reminded here many times. It didnt help that CRML IPO did not have much PIPE. It's also worth mentioning the risk of dilution post 60 days grace period. That's really what Tony referred to of risk of being swallowed up, and I agree.
There's little care about CRML amongst the pool of companies on Nasdaq since it hasn't released financials yet as a company. No balance sheet = can't diligence. EUR is same, as they are only released to market every half yearly or EOFY.
EUR Price at posting:
7.7¢ Sentiment: Buy Disclosure: Held
